Form 4: Blackstone Director Joseph Baratta Granted 51,216 Shares
Insider Transaction Report
Blackstone Inc. Director Joseph Baratta was granted 51,216 deferred restricted shares of common stock, vesting over three years.
Summary
- Joseph Baratta, a Director of Blackstone Inc. (BX), was granted 51,216 shares of Common Stock.
- The grant occurred on January 12, 2026, under the Amended and Restated 2007 Equity Incentive Plan.
- These are deferred restricted shares with a vesting schedule: 17,072 shares on January 1, 2027, 17,072 shares on January 1, 2028, and 17,072 shares on January 1, 2029.
- Vesting is contingent on Mr. Baratta's continued employment with Blackstone.
- Following this transaction, Mr. Baratta beneficially owns 746,973 shares of Common Stock.
Sentiment
Score: 7
Explanation: The filing reports a routine equity grant to a director, which is a positive for aligning management incentives but does not indicate significant new operational or financial news. It's a standard compensation event.
Positives
- The grant of 51,216 deferred restricted shares to a Director aligns management incentives with shareholder interests.
- The vesting schedule over three years promotes long-term commitment and retention of key personnel.
Negatives
- No immediate cash inflow for the director as shares are restricted and vest over time.
Risks
- Vesting of the granted shares is subject to the Reporting Person's continued employment with Blackstone.
Future Outlook
The deferred restricted shares will vest ratably over a three-year period, contingent on continued employment, indicating a long-term incentive structure for the director. Shares may be delivered earlier upon a change in control of Blackstone.
Industry Context
Equity grants to directors and executives are a standard practice in the financial services industry, particularly for large asset managers like Blackstone, to align leadership interests with long-term company performance and shareholder value.
Comparison to Industry Standards
- Equity-based compensation, such as deferred restricted shares, is a common practice among major financial institutions and asset management firms like KKR & Co. Inc., Apollo Global Management, Inc., and Carlyle Group Inc.
- The three-year ratable vesting schedule is typical for executive and director equity awards, designed to promote long-term retention and performance alignment, comparable to similar plans at peer firms.
- The grant price of $0 is standard for compensatory equity awards, reflecting the nature of the grant as part of a compensation package rather than a purchase.
Stakeholder Impact
- Shareholders: The grant aligns the director's interests with long-term shareholder value creation, as the shares vest over time and are subject to continued employment. It represents a minor dilution potential in the context of total shares outstanding.
- Employees: Reinforces the company's commitment to long-term incentive plans for key personnel.
Next Steps
- Joseph Baratta's continued employment with Blackstone Inc. is required for the shares to vest.
- 17,072 shares will vest on January 1, 2027.
- 17,072 shares will vest on January 1, 2028.
- 17,072 shares will vest on January 1, 2029.
Key Dates
| Date | Description |
|---|---|
| 01/12/2026 | Date of earliest transaction (grant date of deferred restricted shares) |
| 01/14/2026 | Signature date of the Form 4 filing |
| 01/01/2027 | First vesting date for 17,072 shares |
| 01/01/2028 | Second vesting date for 17,072 shares |
| 01/01/2029 | Third vesting date for 17,072 shares |
Recommendation
holdThis Form 4 filing details a routine equity grant to a director as part of an existing compensation plan. It does not present new information that would fundamentally alter the investment thesis for Blackstone Inc. While aligning management incentives, it's a standard event and does not warrant a change in investment recommendation based solely on this filing. Investors should continue to hold based on broader company fundamentals and market conditions.
Keywords
Blackstone, BX, Joseph Baratta, SEC Form 4, Stock Grant, Equity Incentive Plan, Deferred Restricted Shares, Director Compensation, Insider Transaction
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.